Castle Biosciences Inc (CSTL) — Cash Flow Reinvestment Rate
Castle Biosciences Inc (CSTL) has a Cash Flow Reinvestment Rate of 1.47x as of September 2025, reinvesting $33.22 Million (capex $14.83 Million plus investments $-18.39 Million) from operating cash flow of $22.63 Million. Explore Castle Biosciences Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Castle Biosciences Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Castle Biosciences Inc across 3 annual periods. Also explore how large is Castle Biosciences Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Castle Biosciences Inc (2019–2024)
Year-by-year capital reinvestment analysis for Castle Biosciences Inc. For live market cap and broader valuation context, see CSTL market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.21x | $78.46 Million | $64.87 Million | $28.33 Million | ▲ +25.6% |
| 2020 | 0.96x | $9.50 Million | $9.87 Million | $4.75 Million | ▲ +260.4% |
| 2019 | 0.27x | $1.87 Million | $7.01 Million | $937.00K | — |